- Home
- OFLX vs RLMD Comparison
OFLX vs RLMD Comparison
Compare OFLX & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OFLX | RLMD |
|---|---|---|
| Founded | 1975 | 2004 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.0M | 319.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OFLX | RLMD |
|---|---|---|
| Price | $36.75 | $3.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 44.7K | ★ 519.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.68% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $23.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.58 | $0.24 |
| 52 Week High | $42.08 | $5.12 |
Technical Indicators
Market Signals| Indicator | OFLX | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 63.35 | 49.60 |
| Support Level | $35.35 | $3.45 |
| Resistance Level | $37.92 | $4.35 |
| Average True Range (ATR) | 1.70 | 0.32 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 85.40 | 60.35 |
Price Performance
Historical ComparisonAbout OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.